Stockscreener 앱 받기
3.64
5.45%
-0.21
시간 외 거래:
3.63
-0.01
-0.27%
Exagen Inc 주식(XGN)의 최신 뉴스
Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time - MSN
Exagen Inc. (XGN) reports Q1 loss, beats revenue estimates - MSN
Record revenue growth and higher test pricing keep Exagen (XGN) in focus despite ongoing losses - MSN
Earnings call transcript: Exagen Inc. beats Q1 2026 expectations, stock surges - Investing.com Nigeria
Exagen Inc. (NASDAQ:XGN) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
The Exagen Inc. (NASDAQ:XGN) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
Exagen Targets $73 Million Revenue for 2026 as Test Volumes Surge - HarianBasis.co
Exagen Inc. (NASDAQ:XGN) Q1 2026 Earnings Call Transcript - Insider Monkey
TradingKey - TradingKey
Exagen Achieves Record Q1 Revenue Driven by AVISE CTD Adoption - HarianBasis.co
Analysts Offer Insights on Healthcare Companies: Exagen (XGN) and Liquidia Technologies (LQDA) - The Globe and Mail
Exagen (XGN) Q1 2026 Earnings Transcript - AOL.com
Exagen Inc stock (US30063K1051): Q1 revenue hits record $17.3M, up 12% - AD HOC NEWS
XGN Maintained by BTIG -- Price Target Lowered to $8.00 - GuruFocus
CCORF Maintains Exagen(XGN.US) With Buy Rating, Maintains Target Price $8 - Moomoo
BTIG Maintains Exagen(XGN.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
Exagen Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Exagen stock price target lowered to $8 by BTIG on valuation - Investing.com UK
Exagen Inc (XGN) Q1 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid Challenges - GuruFocus
Exagen (XGN) Reports Record Q1 Revenue of $17.3 Million, Up 12% Year-Over-Year - GuruFocus
Exagen | 10-Q: Q1 2026 Earnings Report - Moomoo
Number of shareholders of Exagen, Inc. – FWB:E08A - TradingView
Exagen Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:XGN) 2026-05-12 - Seeking Alpha
TD Cowen Maintains Exagen(XGN.US) With Buy Rating, Cuts Target Price to $8 - Moomoo
Is Exagen (XGN) 30.9% Overvalued After Q1 2026 Earnings? EPS -0. - GuruFocus
Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Exagen Q1 earnings call highlights - MSN
XGN Maintains Revenue Forecast for 2026 - GuruFocus
Exagen Inc. Achieves Record $17.3 Million Q1 2026 Revenue - HarianBasis.co
Exagen (XGN) Achieves Strong Q1 Revenue Exceeding Expectations - GuruFocus
Exagen Q1 Earnings Call Highlights - Inkl
Exagen (NASDAQ:XGN) Issues Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
Exagen Inc. Reaffirms Earnings Guidance for the full year 2026 - marketscreener.com
Record Revenue Growth and Higher Test Pricing Keep Exagen (XGN) in Focus Despite Ongoing Losses - Yahoo Finance
XGN: Record revenue, higher ASP, and strong test volume growth drive positive 2026 outlook - TradingView
Exagen Hits Record Q1 Revenue, Signals Path to Profitability - BriefGlance
Exagen Releases Q1 2026 Financial Results - AlphaStreet
XGN: Q1 2026 revenue up 12% to $17.3M, with margin and ASP gains; guidance reaffirmed - TradingView
Exagen Inc. Reports Record Q1 2026 Revenue and AVISE CTD Average Selling Price - Minichart
Exagen Inc. (NASDAQ:XGN) Soars on Q1 2026 Earnings Beat as Record Revenue and Narrowed Loss Fuel Pre-Market Rally - ChartMill
EXAGEN INC. 1Q 2026: Revenue $17.31M, EPS $(0.17) — 10-Q Summary - TradingView
Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Exagen (NASDAQ: XGN) grows Q1 2026 revenue to $17.3M but remains loss-making - Stock Titan
Autoimmune test maker Exagen lifts prices, posts record $17.3M quarter - Stock Titan
Exagen reports Q1 2026 revenue $17.3M, adjusted EBITDA loss narrows to $2.16M - TradingView
XGN: Q1 2026 delivered record revenue, improved margins, and reaffirmed strong full-year guidance - TradingView
Exagen (XGN) posts record Q1 2026 revenue and higher AVISE CTD pricing - Stock Titan
Exagen Inc. Reports First Quarter 2026 Results - Caledonian Record
BRIEF-Exagen Inc. Q1 Revenue USD 17.306 Million Vs. IBES Estimate USD 16.4 Million - TradingView
0.71%
자본화:
|
볼륨(24시간):